ArticleThe oncologist2016

Safety of an Oral Fixed Combination of Netupitant and Palonosetron (NEPA): Pooled Data From the Phase II/III Clinical Program.

Matti Aapro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.